Makoto Ueno
Papers
1
Total Citations
9
H-Index
1
About
Dr. Makoto Ueno is a leading figure in surgical oncology, with a primary focus on advancing the treatment of pancreatic cancer. His research is centered on the critical evaluation of minimally invasive surgical techniques, particularly distal pancreatectomy, and their oncologic safety compared to traditional open surgery. Dr. Ueno’s major contribution is his leadership in the Japan Clinical Oncology Group study JCOG2202 (LAPAN study), a multi-institutional, randomized phase III trial that directly compares minimally invasive distal pancreatectomy (MIDP) with open distal pancreatectomy for pancreatic cancer. This landmark study, published in 2024, addresses the crucial question of whether the favorable short-term outcomes of MIDP can be achieved without compromising long-term oncologic results. With 9 citations already, this work is poised to significantly influence global surgical guidelines. By spearheading this rigorous, high-level evidence, Dr. Ueno is providing the definitive data needed to guide clinical decision-making, ultimately aiming to improve both recovery and survival for patients with pancreatic cancer.
Research Focus
Key Achievements
Top Papers
- 1